These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis. Rawal T; Kremer L; Halloum I; Butani S J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480 [TBL] [Abstract][Full Text] [Related]
3. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations. Lin YW; Wong J; Qu L; Chan HK; Zhou QT Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193 [TBL] [Abstract][Full Text] [Related]
4. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles. Weers JG; Miller DP; Tarara TE AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187 [TBL] [Abstract][Full Text] [Related]
5. Advances in device and formulation technologies for pulmonary drug delivery. Chan JG; Wong J; Zhou QT; Leung SS; Chan HK AAPS PharmSciTech; 2014 Aug; 15(4):882-97. PubMed ID: 24728868 [TBL] [Abstract][Full Text] [Related]
6. Dry powder inhalation: past, present and future. de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768 [TBL] [Abstract][Full Text] [Related]
7. Technological and practical challenges of dry powder inhalers and formulations. Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675 [TBL] [Abstract][Full Text] [Related]
8. Dry powder inhalable formulations for anti-tubercular therapy. Parumasivam T; Chang RY; Abdelghany S; Ye TT; Britton WJ; Chan HK Adv Drug Deliv Rev; 2016 Jul; 102():83-101. PubMed ID: 27212477 [TBL] [Abstract][Full Text] [Related]
9. Formulation Design of Dry Powders for Inhalation. Weers JG; Miller DP J Pharm Sci; 2015 Oct; 104(10):3259-88. PubMed ID: 26296055 [TBL] [Abstract][Full Text] [Related]
10. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™). Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate. Mehta R; Moore A; Riddell K; Joshi S; Chan R J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040 [TBL] [Abstract][Full Text] [Related]
12. High dose dry powder inhalers to overcome the challenges of tuberculosis treatment. Momin MAM; Tucker IG; Das SC Int J Pharm; 2018 Oct; 550(1-2):398-417. PubMed ID: 30179703 [TBL] [Abstract][Full Text] [Related]
13. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development. Le VN; Robins E; Flament MP Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906 [TBL] [Abstract][Full Text] [Related]
15. Dry powder inhalers in COPD, lung inflammation and pulmonary infections. Muralidharan P; Hayes D; Mansour HM Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926 [TBL] [Abstract][Full Text] [Related]
16. Dose emission characteristics of placebo PulmoSphere® particles are unaffected by a subject's inhalation maneuver. Weers J; Ung K; Le J; Rao N; Ament B; Axford G; Maltz D; Chan L J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):56-68. PubMed ID: 22691109 [TBL] [Abstract][Full Text] [Related]
17. Formulation techniques for high dose dry powders. Brunaugh AD; Smyth HDC Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822 [TBL] [Abstract][Full Text] [Related]
18. How can we bring high drug doses to the lung? Claus S; Weiler C; Schiewe J; Friess W Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444 [TBL] [Abstract][Full Text] [Related]
19. Delivery Technologies for Orally Inhaled Products: an Update. Moon C; Smyth HDC; Watts AB; Williams RO AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904 [TBL] [Abstract][Full Text] [Related]
20. A review of co-milling techniques for the production of high dose dry powder inhaler formulation. Lau M; Young PM; Traini D Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]